Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | KIF11 | P52732 | 1/20 | 0.39 |
| ▸ | ACP3 | P15309 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29427756 | 1.00 | ALDH1A1 (0.44) | ALDH1A1TDP1POLBL3MBTL1IDO1 | |
| Hydrochloric Acid SCHEMBL27584626 | 0.97 | ALDH1A1 (0.48) | ALDH1A1TDP1POLBL3MBTL1IDO1 | |
| SCHEMBL28228479 | 0.97 | ALDH1A1 (0.43) | ALDH1A1TDP1POLBL3MBTL1IDO1 | |
| Ammonia Solution, Strong SCHEMBL28874104 | 0.97 | ALDH1A1 (0.43) | ALDH1A1TDP1POLBL3MBTL1IDO1 | |
| SCHEMBL27306666 | 0.83 | ALDH1A1 (0.38) | ALDH1A1TDP1POLBL3MBTL1IDO1 | |
| SCHEMBL5315536 | 0.81 | ALDH1A1 (0.36) | ALDH1A1TDP1POLBL3MBTL1IDO1 | |
| SCHEMBL27305380 | 0.81 | ALDH1A1 (0.36) | ALDH1A1TDP1POLBL3MBTL1IDO1 | |
| SCHEMBL944584 | 0.81 | ALDH1A1 (0.36) | ALDH1A1TDP1POLBL3MBTL1IDO1 | |
| SCHEMBL63469 | 0.81 | ALDH1A1 (0.52) | ALDH1A1TDP1POLBL3MBTL1IDO1 | |
| SCHEMBL29441997 | 0.81 | ALDH1A1 (0.52) | ALDH1A1TDP1POLBL3MBTL1IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 795 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260123372-A1 | MANUFACTURING SEMICONDUCTOR DEVICE USING SELECTIVE DIELECTRIC ON DIELECTRIC (DOD) DEPOSITION PROCESS | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2026-04-30 | — | — | US | claimed |
| EP-4004955-B1 | FERROFLUID SYSTEM CONTAINING GOLD PARTICLES | RICHEMONT INT SA (CH) | 2026-04-22 | — | — | EP | claimed |
| US-12518966-B2 | Selective plasma enhanced atomic layer deposition | VERSUM MATERIALS US, LLC (US) | 2026-01-06 | — | — | US | claimed |
| US-20250167304-A1 | LITHIUM ION BATTERY | SVOLT ENERGY TECHNOLOGY CO., LTD. (CN) | 2025-05-22 | — | — | US | claimed |
| CN-119954826-A | Compound, preparation method and application thereof, lithium ion battery electrolyte additive and electrolyte | 华鼎国联动力电池有限公司 | 2025-05-09 | — | — | CN | claimed |
| CN-119678257-A | Battery and electronic equipment | 珠海冠宇电池股份有限公司 | 2025-03-21 | — | — | CN | claimed |
| CN-119481270-A | High-voltage electrolyte and application thereof in lithium-rich manganese-based positive electrode system | 苏州埃米特材料科技有限公司 | 2025-02-18 | — | — | CN | claimed |
| EP-4465401-A1 | LITHIUM ION BATTERY | SVOLT Energy Technology Co., Ltd. (CN) | 2024-11-20 | — | — | EP | claimed |
| CN-118867372-A | Use of trifluoromethyl phenyl sulfide derivative | 陕西亚典娜电力能源有限责任公司 | 2024-10-29 | — | — | CN | claimed |
| CN-118380656-B | Electrolyte and lithium-sulfur battery | 蜂巢能源科技股份有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-102936227-A | Preparation method of ponazuril | QILU ANIMAL HEALTH PRODUCTS CO | 2013-02-20 | — | — | CN | claimed |
| CN-102108067-B | Method for preparing toltrazuril | GUANGDONG TIANBAO BIOLOG PHARMACEUTICAL CO LTD | 2012-10-03 | — | — | CN | claimed |
| CN-101265236-B | Synthesis technique for toltrazuril | WUXUE LONGXIANG MEDICINE CO LTD | 2012-05-23 | — | — | CN | claimed |
| CN-102391424-A | Method for modifying styrene-butadiene-styrene (SBS) block copolymer | UNIV SHANGHAI JIAOTONG | 2012-03-28 | — | — | CN | claimed |
| CN-102108067-A | Method for preparing toltrazuril | GUANGDONG TIANBAO BIOLOG PHARMACEUTICAL CO LTD | 2011-06-29 | — | — | CN | claimed |
| CN-101265236-A | Synthesis technique for toltrazuril | WUXUE LONGXIANG MEDICINE CO LT (CN) | 2008-09-17 | — | — | CN | claimed |
| CN-1927846-A | Preparation method of coccidiostat methyl triazon for animal | SHANGDONG XINFA PHARMACRUTICAL (CN) | 2007-03-14 | — | — | CN | claimed |
| CN-1590371-A | Preparation method of substituted thiophenol | UNIV ZHEJIANG POLYTECHNIC (CN) | 2005-03-09 | — | — | CN | claimed |
| US-5283016-A | Method for preparing photosensitive microcapsules | THE MEAD CORPORATION (US) | 1994-02-01 | — | — | US | claimed |
| CN-1041948-A | New this glucosides of B-D-phenyl sulfo-and preparation method thereof and therepic use | FOURNIER INNOVATION SYNERGIE (FR) | 1990-05-09 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260123372-A1 | MANUFACTURING SEMICONDUCTOR DEVICE USING SELECTIVE DIELECTRIC ON DIELECTRIC (DOD) DEPOSITION PROCESS | PDK1, HPD, HAO2 | ALDH1A1 41/4885TDP1 545/4885POLB 803/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.